| Recent advances in understanding the protein corona of nanoparticles and in the formulation of “stealthy” nanomaterials R Rampado, S Crotti, P Caliceti, S Pucciarelli, M Agostini Frontiers in bioengineering and biotechnology 8, 166, 2020 | 258 | 2020 |
| A specific mutational signature associated with DNA 8-oxoguanine persistence in MUTYH-defective colorectal cancer A Viel, A Bruselles, E Meccia, M Fornasarig, M Quaia, V Canzonieri, ... EBioMedicine 20, 39-49, 2017 | 203 | 2017 |
| Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer J Chen, I Guccini, D Di Mitri, D Brina, A Revandkar, M Sarti, E Pasquini, ... Nature genetics 50 (2), 219-228, 2018 | 167 | 2018 |
| Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy M Agostini, S Pucciarelli, MV Enzo, P Del Bianco, M Briarava, C Bedin, ... Annals of surgical oncology 18 (9), 2461-2468, 2011 | 155 | 2011 |
| Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy M Agostini, S Pucciarelli, MV Enzo, P Del Bianco, M Briarava, C Bedin, ... Annals of surgical oncology 18 (9), 2461-2468, 2011 | 155 | 2011 |
| Extracellular matrix and colorectal cancer: how surrounding microenvironment affects cancer cell behavior? S Crotti, M Piccoli, F Rizzolio, A Giordano, D Nitti, M Agostini Journal of cellular physiology 232 (5), 967-975, 2017 | 142 | 2017 |
| Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease L Terrin, E Rampazzo, S Pucciarelli, M Agostini, R Bertorelle, G Esposito, ... Clinical Cancer Research 14 (22), 7444-7451, 2008 | 113 | 2008 |
| Diagnostic and prognostic role of cell‐free DNA testing for colorectal cancer patients C Bedin, MV Enzo, P Del Bianco, S Pucciarelli, D Nitti, M Agostini International journal of cancer 140 (8), 1888-1898, 2017 | 111 | 2017 |
| Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients M Agostini, MV Enzo, C Bedin, V Belardinelli, E Goldin, P Del Bianco, ... Cancer Biomarkers 11 (2-3), 89-98, 2012 | 99 | 2012 |
| Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers A Parodi, C Corbo, A Cevenini, R Molinaro, R Palomba, L Pandolfi, ... Nanomedicine 10 (12), 1923-1940, 2015 | 84 | 2015 |
| Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research M Piccoli, E D'Angelo, S Crotti, F Sensi, L Urbani, E Maghin, A Burns, ... Journal of Cellular Physiology 233 (8), 5937-5948, 2018 | 83 | 2018 |
| Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer R Bertorelle, M Briarava, E Rampazzo, L Biasini, M Agostini, I Maretto, ... British journal of cancer 108 (2), 278-284, 2013 | 83 | 2013 |
| Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAFV600E: A non-invasive tool panel for early detection of thyroid cancer M Zane, M Agostini, MV Enzo, EC Ide, P Del Bianco, F Torresan, ... Biomedicine & Pharmacotherapy 67 (8), 723-730, 2013 | 80 | 2013 |
| Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy E Cecchin, M Agostini, S Pucciarelli, A De Paoli, V Canzonieri, R Sigon, ... The pharmacogenomics journal 11 (3), 214-226, 2011 | 80 | 2011 |
| An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer M Agostini, KP Janssen, E D'Angelo, S Pizzini, A Zangrando, C Zanon, ... Oncotarget 6 (32), 32561, 2015 | 77 | 2015 |
| Two PMS2 mutations in a Turcot syndrome family with small bowel cancers. VA Agostini M, Tibiletti Mg, Lucci-Cordisco E, Chiaravalli A, Morreau H ... Am J Gastroenterol 100 (8), 1886-91, 2005 | 75* | 2005 |
| Telomere-specific reverse transcriptase (hTERT) and cell-free RNA in plasma as predictors of pathologic tumor response in rectal cancer patients receiving neoadjuvant … S Pucciarelli, E Rampazzo, M Briarava, I Maretto, M Agostini, M Digito, ... Annals of Surgical Oncology 19, 3089-3096, 2012 | 73 | 2012 |
| Engineered biomimetic nanovesicles show intrinsic anti-inflammatory properties for the treatment of inflammatory bowel diseases C Corbo, WE Cromer, R Molinaro, NET Furman, KA Hartman, E De Rosa, ... Nanoscale 9 (38), 14581-14591, 2017 | 70 | 2017 |
| A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation S Terrazzino, M Agostini, S Pucciarelli, LM Pasetto, ML Friso, A Ambrosi, ... Pharmacogenetics and genomics 16 (11), 817-824, 2006 | 70 | 2006 |
| Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy S Bayda, M Hadla, S Palazzolo, V Kumar, I Caligiuri, E Ambrosi, ... Journal of Controlled Release 248, 144-152, 2017 | 69 | 2017 |
Salvatore PucciarelliVerified email at unipd.it
